Screener / SEC EDGAR /CIK 0001520262 /10-K filed Feb 25, 2026, compared with Feb 12, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Alkermes plc. ALKS

Compare with peers Embed
Planned sales, announced before they happen

11 trading plans running, 27 Form 144 notices for $9.2M

10-Q, 10-K and Form 144
Plans running now 11 Shane Cooke, Dr. Christopher Wright, Dr. Cato Laurencin, Blair Jackson, Samuel Parisi, Christian Todd Nichols, Richard Pops, Christopher Wright, David Gaffin
Plans adopted 20 reported since Apr 26, 2023 Form 144 notices 27 $9.2M the sellers expected to sell

What ALKS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Nov 19, 2025 to Dec 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Shane Cooke
director
Adopted 10b5-1 plan Aug 31, 2026 10-Q Nov 3, 2026
Dr. Christopher Wright
director
Adopted 10b5-1 plan Aug 21, 2026 10-Q Nov 3, 2026
Dr. Cato Laurencin
director
Adopted 10b5-1 plan Aug 6, 2026 10-Q Nov 3, 2026
Blair Jackson
Chief Operating Officer
Adopted 10b5-1 plan Jun 12, 2026 10-Q Jul 28, 2026
Samuel Parisi
Interim Principal Accounting Officer
Adopted 10b5-1 plan Jun 8, 2026 10-Q Jul 28, 2026
Christian Todd Nichols
Chief Commercial Officer
Adopted 10b5-1 plan May 15, 2026 10-Q Jul 28, 2026
Richard Pops
Chairman and Chief Executive Officer
Adopted 10b5-1 plan Mar 12, 2026 10-Q May 5, 2026
Christopher Wright
M.D., Ph.D., a director of the Company
Adopted 10b5-1 plan Mar 11, 2026 10-Q May 5, 2026
Blair Jackson
Executive Vice President, Chief Operating Officer
Adopted 10b5-1 plan Nov 19, 2025 10-K Feb 25, 2026
Christian Todd Nichols
Senior Vice President, Chief Commercial Officer
Adopted 10b5-1 plan Nov 19, 2025 10-K Feb 25, 2026
David Gaffin
Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary
Adopted 10b5-1 plan Nov 19, 2025 10-K Feb 25, 2026
Richard Pops
Chairman and Chief Executive Officer
Adopted 10b5-1 plan Nov 19, 2025 10-K Feb 25, 2026
Samuel Parisi
Vice President, Finance and Interim Principal Accounting Officer
Adopted 10b5-1 plan Nov 7, 2025 10-K Feb 25, 2026
Nancy Lurker
director
Adopted 10b5-1 plan Jun 13, 2025 10-Q Jul 29, 2025
Christian Todd Nichols
Senior Vice President Chief Commercial Officer
Adopted 10b5-1 plan Mar 10, 2025 10-Q May 1, 2025
Shane Cooke
director
Adopted 10b5-1 plan Feb 27, 2025 10-Q May 1, 2025
Craig Hopkinson
Executive Vice President, Research and Development and Chief Medical Officer
Ended 10b5-1 plan Feb 14, 2025 10-Q May 1, 2025
Samuel Parisi
VP
Adopted 10b5-1 plan Sep 11, 2024 10-Q Oct 24, 2024
Christian Todd Nichols
Senior Vice President
Adopted 10b5-1 plan Aug 23, 2024 10-Q Oct 24, 2024
Christian Todd Nichols
Senior Vice President Chief Commercial Officer
Adopted 10b5-1 plan Dec 14, 2023 10-K Feb 21, 2024
Craig Hopkinson, M.D
Executive Vice President
Adopted 10b5-1 plan Dec 14, 2023 10-K Feb 21, 2024
Show the other 13 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 16 filings checked since Apr 26, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 3, 2026 Gaffin David Joseph
Officer
2,035 $94K
Oct 2, 2026 Gaffin David Joseph
Officer
2,034 $83K
Sep 3, 2026 Gaffin David Joseph
Officer
2,034 $98K
Sep 1, 2026 Hopkinson Craig C.
Officer
9,000 $423K
Aug 17, 2026 Nichols Christian Todd
Officer
7,576 $373K
Aug 3, 2026 snyderman nancy lynn MD
Officer
44,472 $2.2M
Aug 3, 2026 Gaffin David Joseph
Officer
2,034 $99K
Aug 3, 2026 Hopkinson Craig C.
Officer
9,000 $437K
Jul 6, 2026 Gaffin David Joseph
Officer
2,034 $110K
Jul 1, 2026 Hopkinson Craig C.
Officer
9,000 $464K
Jun 12, 2026 Wright Christopher I
Officer
2,000 $90K
Jun 4, 2026 Gaffin David Joseph
Officer
2,034 $88K
Jun 1, 2026 Hopkinson Craig C.
Officer
9,000 $375K
May 4, 2026 Gaffin David Joseph
Officer
2,034 $68K
May 1, 2026 Hopkinson Craig C.
Officer
9,000 $301K
Apr 6, 2026 Gaffin David Joseph
Officer
2,034 $70K
Apr 1, 2026 Hopkinson Craig C.
Officer
9,000 $320K
Mar 3, 2026 Gaffin David Joseph
Officer
2,034 $61K
Mar 2, 2026 Nichols Christian Todd
Officer
6,000 $180K
Mar 2, 2026 Gaffin David Joseph
Officer
2,034 $60K
Mar 2, 2026 Hopkinson Craig C.
Officer
9,000 $267K
Feb 2, 2026 Cooke Shane
Officer
61,200 $2.1M
Feb 2, 2026 Hopkinson Craig C.
Officer
9,000 $305K
Jan 8, 2026 Hopkinson Craig C.
Officer
5,000 $150K
Jan 2, 2026 Hopkinson Craig C.
Officer
4,000 $112K
Dec 3, 2025 Hopkinson Craig C.
Officer
3,748 $112K
Dec 1, 2025 Hopkinson Craig C.
Officer
4,000 $117K
Show the other 19 notices

From the Form 144 XML filed with the SEC, since Dec 1, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ALKS/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.